NRC
GILD icon

New Republic Capital’s Gilead Sciences GILD Stock Holding History

New Republic Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$378K Sell
2,715
-1,251
-32% -$175K 0.13% 149
2025
Q4 		$487K Buy
3,966
+1,993
+101% +$242K 0.13% 141
2025
Q3 		$219K Buy
1,973
+47
+2% +$5.34K 0.07% 176
2025
Q2 		$214K Buy
+1,926
New +$205K 0.08% 168

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

New Republic Capital's GILD Position: Q1 2026 in Review

New Republic Capital reduced its Gilead Sciences (GILD) stake by 32% in Q1 2026, selling an estimated $175K and leaving 2,715 shares worth $378K. The position accounts for 0.13% of the portfolio, ranked #149.

New Republic Capital first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $487K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • New Republic Capital held 2,715 shares of Gilead Sciences worth $378K as of Q1 2026.
  • New Republic Capital sold 1,251 Gilead Sciences shares in Q1 2026, an estimated $175K.
  • Gilead Sciences made up 0.13% of New Republic Capital's portfolio in Q1 2026, its #149 holding.
  • New Republic Capital first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • New Republic Capital's Gilead Sciences position peaked at $487K in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.